Mr. Simon Castonguay reports

LUMIERA ANNOUNCES THE RESULTS OF ITS ANNUAL MEETING

Lumiera Health Inc. has released the results of its annual general and special meeting of shareholders, which was held May 19, 2022, by webcast. All of the nominees listed in the company's management information circular dated April 14, 2022, were elected as directors.

Detailed results of the vote for the election of directors are set out in the attached table.

All other matters presented for shareholder approval at the meeting were approved as follows:

• To appoint Richter LLP, chartered accountants, as the auditor of the corporation and to authorize the directors to fix the auditor's remuneration;
• To consider and, if deemed advisable, to pass, with or without variation, an ordinary resolution confirming reapproval of the corporation's incentive stock option plan.

About Lumiera Health Inc.

Lumiera specializes in the development and commercialization of consumer products for the natural health industry. The company sells herbal tonics and natural supplements through its Holizen Laboratories division, with a diverse portfolio, including a line of innovative sleep aids. The company is also commercializing a unique topical product line acting on the endocannabinoid system, without the use of cannabis, that provides an innovative solution for chronic pain and inflammation. A pioneer in the natural health innovation space, the Lumiera brand is rooted in the core values of science, nature and compassion. The company's goal is to make people's lives better by developing natural health and wellness products that are effective, safe and trustworthy.

We seek Safe Harbor.